Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 -0.4889M
June 30, 2026 -0.9443M
March 31, 2026 0.2655M
December 31, 2025 -0.5097M
September 30, 2025 -1.395M
June 30, 2025 -1.751M
March 31, 2025 -1.068M
December 31, 2024 -0.8198M
September 30, 2024 -0.1857M
June 30, 2024 -1.552M
March 31, 2024 -1.659M
December 31, 2023 -1.144M
September 30, 2023 -0.6558M
June 30, 2023 -1.532M
March 31, 2023 -0.3718M
December 31, 2022 -0.1809M
September 30, 2022 -0.5352M
June 30, 2022 -0.8471M
March 31, 2022 -0.4306M
December 31, 2021 -0.4051M
September 30, 2021 -1.075M
June 30, 2021 -0.7104M
March 31, 2021 -0.6077M
December 31, 2020 -0.3209M
September 30, 2020 -0.5178M
Date Value
June 30, 2020 -0.1457M
March 31, 2020 -0.3644M
December 31, 2019 -0.1494M
September 30, 2019 -0.0618M
June 30, 2019 -0.0808M
March 31, 2019 -0.196M
December 31, 2018 -0.3078M
September 30, 2018 -0.1596M
June 30, 2018 -0.3448M
March 31, 2018 -0.259M
December 31, 2017 -0.417M
September 30, 2017 -0.3588M
June 30, 2017 -0.2469M
March 31, 2017 -0.3574M
December 31, 2016 -0.3418M
September 30, 2016 -0.2961M
June 30, 2016 -0.4451M
March 31, 2016 -0.0574M
June 30, 2015 -0.095M
March 31, 2015 -0.092M
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. -6.754M
Sangamo Therapeutics, Inc. -19.28M
Sarepta Therapeutics, Inc. 59.97M
Anixa Biosciences, Inc. -1.77M
Vicapsys Life Sciences, Inc. -0.0051M

Cash from Operations (Quarterly) Related Metrics